Abstract
Lead is a representative heavy metal used in the manufacture of various products. Humans are exposed to lead through their daily and occupational environment. Diverse occupational usage of lead causes long-term and low dose exposure to humans. Although several studies have investigated lead toxicity in the kidneys, lead-induced genotoxicity is poorly studied in the in vivo system of kidney. In this study, we identified the molecular mechanism for biological changes and suggest the possibility of biomarkers through a molecular mechanism under lead exposure. We detected a significant lead-induced genotoxic effect in the kidneys using the comet assay following long term and low dose exposure in vivo. Furthermore, we investigated the signaling networks between lead-induced genotoxicity and the differential expression of the identified genes using a toxicogenomic approach. We identified 4 representative genes (CRY1, PER2, DDIT4, and TET2) which were key in the lead-induced signaling networks. Through the result of our study, we suggest a biomarker of long-term and low level lead exposure, as well as potential biological pathways induced by lead exposure in the kidneys. Our toxicogenomic study reveals biomarkers for the understanding of lead toxicity evaluation in the kidneys, and will be utilized in further studies on the mechanism of lead toxicity in the kidneys.
Similar content being viewed by others
References
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Inorganic and organic lead compounds. IARC Monogr Eval Carcinog Risks Hum 87:1–471 (2006).
Flora, G., Gupta, D. & Tiwari, A. Toxicity of lead: A review with recent updates. Interdiscip Toxicol 5:47–58 (2012).
Duruibe, J. O., Ogwuegbu, M. O. C. & Egwurugwu, J. N. Heavy metal pollution and human biotoxic effects. International Journal of Physical Sciences 2:112–118 (2007).
Verschoor, M., Wibowo, A., Herber, R., van Hemmen, J. & Zielhuis, R. Influence of occupational low-level lead exposure on renal parameters. American journal of industrial medicine 12:341–351 (1987).
Needleman, H. Lead poisoning. Annual Review of Medicine 55:209–222 (2003).
Kim, R. et al. A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. Jama 275:1177–1181 (1996).
Staessen, J. A. et al. Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N Engl J Med 327:151–156 (1992).
Hu, H. et al. The relationship of bone and blood lead to hypertension. The Normative Aging Study. Jama 275: 1171–1176 (1996).
Schwartz, J. Lead, blood pressure, and cardiovascular disease in men and women. Environ Health Perspect 91:71–75 (1991).
Cheng, Y. et al. Electrocardiographic conduction disturbances in association with low-level lead exposure (the Normative Aging Study). Am J Cardiol 82:594–599 (1998).
Park, S. K. et al. Low-level lead exposure, metabolic syndrome, and heart rate variability: the VAN or mative Aging Study. Environ Health Perspect 114:1718–1724 (2006).
Loghman-Adham, M. Renal effects of environmental and occupational lead exposure. Environ Health Perspect 105:928–938 (1997).
Abdel Moneim, A. E., Dkhil, M. A. & Al-Quraishy, S. The protective effect of flaxseed oil on lead acetate-induced renal toxicity in rats. J Hazard Mater 194:250–255 (2011).
Oyagbemi, A. A. et al. Lack of reversal of oxidative damage in renal tissues of lead acetate-treated rats. Environ Toxicol 30:1235–1243 (2015).
Oberley, T. D., Friedman, A. L., Moser, R. & Siegel, F. L. Effects of lead administration on developing rat kidney.II.Functional, morphologic, and immunohistochemical studies. Toxicol Appl Pharmacol 131:94–107 (1995).
Karimfar, M. H., Bargahi, A., Moshtaghi, D. & Farzadinia, P. Long-Term Exposure of Lead Acetate on Rabbit Renal Tissue. Iran Red Crescent Med J 18:e22157 (2016).
Danadevi, K., Rozati, R., Saleha Banu, B., Hanumanth Rao, P. & Grover, P. DNA damage in workers exposed to lead using comet assay. Toxicology 187:183–193 (2003).
Palus, J. et al. Genotoxic effects of occupational exposure to lead and cadmium. Mutat Res 540:19–28 (2003).
Kang, S. H., Kwon, J. Y., Lee, J. K. & Seo, Y. R. Recent advances in in vivo genotoxicity testing: prediction of carcinogenic potential using comet and micronucleus assay in animal models. J Cancer Prev 18:277–288 (2013).
Bouton, C. M., Hossain, M A., Frelin, L. P., Laterra, J. & Pevsner, J. Microarray analysis of differential gene expression in lead-exposed astrocytes. Toxicol Appl Pharmacol 176:34–53 (2001).
Peterson, S. M., Zhang, J, Weber, G & Freeman, J. L. Global gene expression analysis reveals dynamic and developmental stage-dependent enrichment of lead-induced neurological gene alterations. Environ Health Perspect 119:615–621 (2011).
Lesko, L. J. & Woodcock, J. Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective. Nat Rev Drug Discov 3:763–769 (2004).
Lord, P. G. Progress in applying genomics in drug development. Toxicol Lett 149:371–375 (2004).
Koedrith, P., Kim, H., Weon, J. I. & Seo, Y. R. Toxicogenomic approaches for understanding molecular mechanisms of heavy metal mutagenicity and carcinogenicity. Int J Hyg Environ Health 216:587–598 (2013).
Alcaraz-Contreras, Y. et al. Silymarin and dimercaptosuccinic acid ameliorate lead-induced nephrotoxicity and genotoxicity in rats. Hum Exp Toxicol 35:398–403 (2016).
Devi, K. D., Banu, B. S., Grover, P. & Jamil, K. Genotoxic effect of lead nitrate on mice using SCGE (comet assay). Toxicology 145:195–201 (2000).
Schena, M., Shalon, D., Davis, R. W. & Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary DNA microacdcrray. Science 270:467–470 (1995).
Hayes, K. R. & Bradfield, C. A. Advances in toxicogenomics. Chem Res Toxicol 18:403–414 (2005).
Cliby, W. A. et al. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J 17:159–169 (1998).
Wright, J. A. et al. Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. Proc Natl Acad Sci USA 95:7445–7450 (1998).
Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499–506 (2003).
Ko, C. H. & Takahashi, J. S. Molecular components of the mammalian circadian clock. Hum Mol Genet 15 Spec No 2: R271–277 (2006).
Matsuo, T. et al. Control mechanism of the circadian clock for timing of cell division in vivo. Science 302:255–259 (2003).
Unsal-Kacmaz, K, Mullen, T. E., Kaufmann, W. K. & Sancar, A. Coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol 25:3109–3116 (2005).
Kondratov, R. V. & Antoch, M. P. Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol 17:311–317 (2007).
Lee, C. C. The circadian clock and tumor suppression by mammalian period genes. Methods Enzymol 393:852–861 (2005).
Gery, S. et al. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 22:375–382 (2006).
Song, C. X. & He, C. Potential functional roles of DNA demethylation intermediates. Trends Biochem Sci 38:480–484 (2013).
Ko, M. et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468:839–843 (2010).
Solary, E., Bernard, O. A., Tefferi, A., Fuks, F. & Vainchenker, W. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia 28:485–496 (2014).
Ko, M. et al. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc Natl Acad Sci USA 108:14566–14571 (2011).
Eden, A., Gaudet, F., Waghmare, A. & Jaenisch, R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300:455 (2003).
Gal-Yam, E. N., Saito, Y., Egger, G. & Jones, P. A. Cancer epigenetics: modifications, screening, and therapy. Annu Rev Med 59:267–280 (2008).
Ellisen, L. W. et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 10: 995–1005 (2002).
Jia, W et al. REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer. Int J Clin Exp Pathol 7:5940–5949 (2014).
Whitney, M. L., Jefferson, L. S. & Kimball, S. R. ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression. Biochem Biophys Res Commun 379:451–455 (2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, H.S., Lee, H.J., Kim, Y.J. et al. A toxicogenomic study for the investigation of genotoxicity-related signaling networks in long-term and low dose lead exposed rat kidney. Mol. Cell. Toxicol. 12, 437–445 (2016). https://doi.org/10.1007/s13273-016-0048-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13273-016-0048-4